Clinical Trial Update: A Multicentre Trial to Determine the Efficacy and Safety of AD-337 in the Treatment of Fibromyalgia [Phase 2]

View source ↗

Summary

A multicentre Phase 2 trial evaluating the efficacy and safety of AD-337 in fibromyalgia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibromyalgia

Drugs mentioned

• AD-337

Snippet

Sponsor: Sosei | Conditions: Fibromyalgia | Phase 2 | Status: COMPLETED